DeepRare, a multi-agent AI system, achieves 10% higher accuracy than expert physicians in diagnosing rare diseases, potentially reducing diagnostic delays and transforming clinical practice with trans...
A new AI system, DeepRare, demonstrates superior accuracy in diagnosing rare diseases using real-time data and self-reflective reasoning, as detailed in a 2026 Nature study, with potential to reduce d...
Recent studies highlight the importance of early LADA diagnosis through combined autoantibody testing, differentiating it from type 2 diabetes for better treatment outcomes. Early detection of LADA th...
